Sigma Foods (SIGMAF) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Consolidated results exceeded expectations in Q2 and H1 2024, with double-digit EBITDA growth mainly driven by Sigma's outstanding performance and operational efficiencies.
Sigma achieved its 13th consecutive quarter of year-on-year revenue growth and record quarterly EBITDA, supported by strong consumer demand and favorable FX in Mexico.
Alpek completed a $75 million annualized savings plan and advanced cost reduction initiatives, helping offset industry headwinds.
Sigma posted its lowest net leverage ratio in nearly 11 years, supported by debt reduction and non-core asset sales.
Sigma appointed Juan Ignacio Amat as CEO of Sigma Europe to drive profitability.
Financial highlights
Sigma's Q2 2024 EBITDA reached an all-time high of $279 million, with record volume and sales in Mexico, the US, and Latin America.
Alpek's accumulated comparable EBITDA was $312 million in H1, on track for full-year guidance of $600 million.
Consolidated revenues reached $4,221 million in Q2 2024, up from $4,197 million in Q1 2024.
2Q24 EBITDA was $445 million, up 23% year-over-year and 5% sequentially.
Net debt decreased by $117 million in Q2 2024 compared to Q1 2024.
Outlook and guidance
2024 consolidated EBITDA guidance raised 5% to $1.59 billion; revenue guidance up 1% to $16.78 billion.
Sigma's full-year revenue guidance revised to $8.85 billion and EBITDA to $1 billion, up 2% and 9% from original projections.
Alpek's 2024 EBITDA guidance maintained at $600 million.
Sigma's new guidance assumes an average exchange rate of 18.5 MXN per USD for H2 2024.
Sigma expects continued strong performance, with margin improvement opportunities and capacity expansions planned in key regions.
Latest events from Sigma Foods
- Record 2Q26 revenue and EBITDA growth drive confidence in full-year $1.1B guidance.SIGMAF
Q2 202622 Jul 2026 - Sigma posts record EBITDA as ALFA finalizes Alpek spin-off and reduces leverage.SIGMAF
Q3 20248 Jul 2026 - Transformation complete; 1Q25 EBITDA US$220M, S&P upgrades to 'BBB', guidance reaffirmed.SIGMAF
Q1 20258 Jul 2026 - Record revenue and EBITDA growth driven by brand strength, efficiency, and innovation.SIGMAF
Corporate presentation3 Jun 2026 - Record Q1 volume, revenue, and EBITDA growth, with 2026 guidance reaffirmed.SIGMAF
Q1 202627 Apr 2026 - Record revenues, margin expansion, Alpek spin-off, and strong 2026 outlook with increased dividends.SIGMAF
Q4 202512 Apr 2026 - Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - Record results and transformation position for growth as Alpek spin-off nears completion.SIGMAF
Q4 202419 Dec 2025 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025